Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

Completed · Not applicable

Conditions studied: Symmetric Limited Morphea

In brief

Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.

Key facts

Study ID

NCT00812188

Run by

University of Texas Southwestern Medical Center

People needed

24

Starts

2004-11-01

Expected to finish

2009-11-01

Last updated by the study team

2019-02-18

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female subjects 18 years of age or older.
• Symmetric limited morphea.

You may not qualify if…

• Known sensitivity to fluocinonide 0.05% cream.
• Clinical evidence of superinfected skin.
• Immunocompromised state (including previously documented HIV).
• Generalized Scleroderma.
• Previous history of skin cancer.
• Non-English speaking subjects.

Where it is running

• UT Southwestern Medical Center at Dallas - Department of Dermatology Clinical Trials — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.